Abiopharma

New Form 4 - TELEFLEX INC Filed: 2025-08-07 AccNo: 0000096943-25-000124 Size: 5 KB

Evolent Announces Second Quarter 2025 Results

INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Manag

New Form DEF 14A - ARTELO BIOSCIENCES, INC. Filed: 2025-08-07 AccNo: 0001640334-25-001376 Size: 1 MB

CytomX Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update

New Form 8-K - XWELL, Inc. Filed: 2025-08-07 AccNo: 0001104659-25-075185 Size: 187 KB Item 8.01: Other Events

Phreesia Investor Relations - Phreesia Sets Release Date for Fiscal Second Quarter 2026 Results

Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update

Biodesix Announces Second Quarter 2025 Results and Highlights

Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates

NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results

Alector Reports Second Quarter 2025 FinancialResults and Provides Business Update

Regeneron Announces Investor Conference Presentations

PacBio Announces Second Quarter 2025 Financial Results

Zymeworks Provides Corporate Update and Reports Second Quarter 2025 Financial Results